New Technology Impacting Immune-Oncology Research Attracts National Audience at First Annual Bio-Trac Symposium

Published on : Published by : Gina Hagler

New Technology Impacting Immune-Oncology Research Attracts National Audience at First Annual Bio-Trac Symposium October 3, 2018 The First Annual Bio-Trac Symposium at the Bioscience Education Center at Montgomery College was sold out with attendees coming in from across the country. The two-day symposium was on Multiplex Immunofluorescence in Immune-Oncology, which is a rapidly advancing technology [….]

Q&A with Immunomic’s Teri Heiland, PhD: What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy

Published on : Published by : Chris Frew

Q&A with Immunomic’s Teri Heiland, PhD What the ‘UNITE’ Technology Platform Could Mean for the Future of Immunotherapy September 25, 2018   Teri Heiland, Ph.D. is the Senior Vice President of Research and Development, and Co-founder, at Immunomic Therapeutics, Inc., a clinical stage biotechnology company pioneering the study of the LAMP-based nucleic acid immunotherapy platforms. [….]